Multifactorial treatment for improvement of renal function and cardiovascular risk: an ATTEMPT for patients with metabolic syndrome and chronic kidney disease

被引：5

作者：

Katsiki, Niki ^{[2
]}

Elisaf, Moses ^{[1
]}

机构：

[1] Univ Ioannina, Sch Med, Dept Internal Med, GR-45110 Ioannina, Greece

[2] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Propedeut Dept Internal Med 1, GR-54006 Thessaloniki, Greece

来源：

CURRENT MEDICAL RESEARCH AND OPINION | 2011年 / 27卷 / 08期

关键词：

Cardiovascular risk; Chronic kidney disease; Metabolic syndrome; Multifactorial treatment; Renal function; Statin; Uric acid; GLOMERULAR-FILTRATION-RATE; CORONARY-HEART-DISEASE; URIC-ACID LEVELS; PERIPHERAL ARTERIAL-DISEASE; TYPE-2; DIABETES-MELLITUS; ALL-CAUSE MORTALITY; GREEK ATORVASTATIN; SUBGROUP ANALYSIS; EVALUATION GREACE; VASCULAR-DISEASE;

D O I：

10.1185/03007995.2011.596410

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1669 / 1672

页数：4

共 50 条

[21] Additive Interaction of Metabolic Syndrome and Chronic Kidney Disease on Cardiac Hypertrophy, and Risk of Cardiovascular Disease in Hypertension
Iwashima, Yoshio
Horio, Takeshi
Kamide, Kei
Tokudome, Takeshi
Yoshihara, Fumiki
Nakamura, Satoko
Ogihara, Toshio
Rakugi, Hiromi
Kawano, Yuhei
[J]. AMERICAN JOURNAL OF HYPERTENSION, 2010, 23 (03) : 290 - 298
[22] Diabetes, Cardiovascular Disease, and Cardiovascular Risk in Patients with Chronic Kidney Disease
De Lima, Jose J. G.
Gowdak, Luis Henrique W.
David-Neto, Elias
Bortolotto, Luiz A.
[J]. HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2021, 28 (02) : 159 - 165
[23] The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Cheng, Fang
Li, Qiang
Wang, Jinglin
Wang, Zhendi
Zeng, Fang
Zhang, Yu
[J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2021, 17 : 1321 - 1331
[24] Insulin Resistance and the Metabolic Syndrome Are Associated With Arterial Stiffness in Patients With Chronic Kidney Disease
Chan, Doris T.
Watts, Gerald F.
Irish, Ashley B.
Ooi, Esther M. M.
Dogra, Gursharan K.
[J]. AMERICAN JOURNAL OF HYPERTENSION, 2013, 26 (09) : 1155 - 1161
[25] Treatment patterns, risk factor control and functional capacity in patients with cardiovascular and chronic kidney disease in the cardiac rehabilitation setting
Voeller, Heinz
Gitt, Anselm
Jannowitz, Christina
Karoff, Marthin
Karmann, Barbara
Pittrow, David
Reibis, Rona
Hildemann, Steven
[J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2014, 21 (09) : 1125 - 1133
[26] Association of Uric Acid with Risk Factors for Chronic Kidney Disease and Metabolic Syndrome in Patients with Essential Hypertension
Seki, Shingo
Tsutsui, Kensuke
Fujii, Takurou
Yamazaki, Kouji
Anzawa, Ryuko
Yoshimura, Michihiro
[J]. CLINICAL AND EXPERIMENTAL HYPERTENSION, 2010, 32 (05) : 270 - 277
[27] Cardiovascular risk factors in patients with chronic kidney disease
van der Zee, Sarina
Baber, Usman
Elmariah, Sammy
Winston, Jonathan
Fuster, Valentin
[J]. NATURE REVIEWS CARDIOLOGY, 2009, 6 (09) : 580 - 589
[28] Cardiovascular risk prediction in chronic kidney disease patients
Cedeno Mora, Santiago
Goicoechea, Marian
Torres, Esther
Verdalles, Ursula
Perez de Jose, Ana
Verde, Eduardo
Garcia de Vinuesa, Soledad
Luno, Jose
[J]. NEFROLOGIA, 2017, 37 (03): : 293 - 300
[29] Resistin Contribution to Cardiovascular Risk in Chronic Kidney Disease Male Patients
Romejko, Katarzyna
Rymarz, Aleksandra
Szamotulska, Katarzyna
Bartoszewicz, Zbigniew
Rozmyslowicz, Tomasz
Niemczyk, Stanislaw
[J]. CELLS, 2023, 12 (07)
[30] Kidney function and the risk of cardiovascular disease in patients with type 2 diabetes
Wang, Yujie
Katzmarzyk, Peter T.
Horswell, Ronald
Zhao, Wenhui
Johnson, Jolene
Hu, Gang
[J]. KIDNEY INTERNATIONAL, 2014, 85 (05) : 1192 - 1199

← 1 2 3 4 5 →